You're reading the free version. Trader adds the live tape and alerts.
Start tracking
AMLX Award Disclosure
Bedrosian Camille L · SEC Form 4 · Filed Aug 20, 2026
Award
Calculated transaction value
$0
Bedrosian Camille L Chief Medical Officer
AMLX
Transaction date
Aug 18, 2026
Public filing date
Aug 20, 2026
Filing lag
Filed 2 days later
AMLX daily price context
Close on/before transaction
$35.11
Aug 18, 2026
First close after public filing
$38.66
Aug 21, 2026
30-day return after filing
-16.22%
Through Sep 21, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 22,807 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001193125-26-359676
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Amylyx Pharmaceuticals, Inc. AMLX Current | Award | Aug 18, 2026 | $0 |